<DOC>
	<DOC>NCT00164086</DOC>
	<brief_summary>The purpose of this trial is to study the effects of a medication already widely used to treat cardiovascular disease and diabetes, in reducing the progression of myeloma.</brief_summary>
	<brief_title>Atorvastatin in Myeloma</brief_title>
	<detailed_description />
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Myeloma in remission Adverse events (AEs) to statin, already on a statin, or contraindication to statin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2005</verification_date>
</DOC>